Sandbox/table: Difference between revisions

Revision as of 15:18, 6 June 2014

**Countries with a reported prevalence <15% of *H. pylori* resistance to clarithromycin**
Europe	North America	South America	Middle East	Far East
Bulgaria (8.7%) Croatia (8%) Germany (2.2–4%) Italy (North) (1.8%) Netherlands (1.7%) Spain (12.9%) Sweden (2.9%) UK (3.9–4.4%)	USA (10.6–12.2%)^†	Brazil (9.8%)	Israel (8.2%)	Hong Kong (4.5%) Japan (11–12.9%) Korea (5.4–5.9%) New Zealand (6.8%)

^† There is a reported prevalence of 15% in the Northeast of the US.

@@ Line 2: / Line 2: @@
 {| style="border: 2px solid #DCDCDC; font-size: 90%; width: 80%;"
-|+ Countries with a reported prevalence <15% of ''H. pylori'' resistance to clarithromycin
+|+ '''Countries with a reported prevalence <15% of ''H. pylori'' resistance to clarithromycin'''
 ! style="background: #DCDCDC;" | Europe
 ! style="background: #DCDCDC;" | North America
@@ Line 19: / Line 19: @@
 * UK (3.9–4.4%)
 | style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top |
-* USA (10.6–12.2%)
+* USA (10.6–12.2%)<sup>†</sup>
 | style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top |
 * Brazil (9.8%)
@@ Line 30: / Line 30: @@
 * New Zealand (6.8%)
 |}
+<SMALL><sup>†</sup> There is a reported prevalence of 15% in the Northeast of the US.</SMALL>